top of page

US Vaccines for India

During the Delta wave in India, we initiated a petition to send excess US vaccines to India

India's Second Wave With a population of 1.3 billion people, India is facing a second wave of COVID-19 that is causing an enormous stress on the country's healthcare infrastructure. The size of the population under threat and the lack of suitable and timely immunization or therapeutic options portends an enormous humanitarian crisis. In addition, scientific research modeling and empirical observations over the past year have demonstrated that sustained high levels of cases in the community result in the emergence of variants that could further prolong this global pandemic.

Maximizing benefits for the US Vaccine Supply As of April 21, 2021, the US has 62 Million doses of highly effective mRNA-based vaccines that are pending administration. While the country is far from completing its vaccination goals, the slowing of the demand for the vaccines is adding approximately 2 million doses every day to the stockpile. Of these, 1 million doses are the Moderna mRNA-1273 vaccine that can be readily distributed using the available infrastructure in cities across India. Every 10 million doses administered in India could result in one less Variant of Concern to contend with in the US later this year.

Let US extend our hand We are requesting the Centers for Disease Control and Prevention (CDC) to recommend to the President of the United States to offer the Moderna mRNA-1273 vaccine doses to India that are in excess in the US as a means to create a global safety net that would benefit the entire world. Please sign this petition to affirm your support.

Chart source: Vaccine Distribution (


bottom of page